EmpowerPharm Inc.

Jun 06, 2024

EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD)

Mar 11, 2024

EMPOWERPHARM AWAITS PHASE II CLINICAL TRIAL ON GROUNDBREAKING TREATMENT TO MANAGE SOCIAL ANXIETY DISORDER

Oct 27, 2020

A Made-in-Canada solution can ensure Canadians are prepared for the impending mental health crisis

Sep 09, 2020

Pioneers of Canada's pharmaceutical industry join forces to tackle the mental health pandemic expected in the wake of COVID